| Project/Area Number |
21790852
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Neurology
|
|---|
| Research Institution | Hoshi University (2010)
Juntendo University (2009) |
|---|
Principal Investigator |
SATO Fumiaki Hoshi University, 薬学部, 助教 (10468580)
|
|---|
| Project Period (FY) |
2009 – 2010
|
| Project Status |
Completed (Fiscal Year 2010)
|
| Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2010: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2009: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Keywords | 神経分子病態学 / パーキンソン病 / リソソーム / 細胞死 / 細胞分画 |
|---|
| Research Abstract |
ATP13A2, identified as one of the causative gene product for familial parkinson's disease (PARK9), localized at lysosomal membrane. The suppression of ATP13A2 expression led to apoptosis in SH-SY5Y cells. The defective expression also was increased an enzyme activity of cathepsins, especially cathepsin D. Moreover, electron microscopy showed the accumulation of high density large structure, which was immunoreacted with antibodies against lamp2 and cathepsin D, in SH-SY5Y cells. These data suggests that PARK9 caused by loss-of-function of ATP13A2 is associated with lysosomal dysfunction, resulting in cell death.
|
